Microengineered surface topography facilitates cell grafting from a prototype hydrogel wound dressing with antibacterial capability

Biotechnology Progress

Volumn 22, Issue 5, 2006, Pages 1407-1415

  Smith, Annie G ^a   Din, Abbas ^a   Denyer, Morgan ^a   Crowther, Nicholas J ^b   Eagland, Donald ^b   Vowden, Kath ^c   Vowden, Peter ^c   Britland, Stephen T ^a,b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b AGT Sciences Ltd   (United Kingdom)

^c BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL; CELL GRAFTING;

BACTERIA; BIOASSAY; CELL CULTURE; MEDICAL PROBLEMS; SKIN; TISSUE CULTURE;

HYDROGELS;

ANTIINFECTIVE AGENT; SILICON;

ADULT; AGED; ARTICLE; BACILLUS SUBTILIS; BANDAGE; CHEMISTRY; ESCHERICHIA COLI; FIBROBLAST; HUMAN; HYDROGEL; MECHANICAL STRESS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BANDAGES; ESCHERICHIA COLI; FIBROBLASTS; HUMANS; HYDROGEL; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; SILICON; STAPHYLOCOCCUS AUREUS; STRESS, MECHANICAL; WOUND HEALING; WOUND INFECTION;

BACILLUS (BACTERIUM); BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 33750010352     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp060192n     Document Type: Article

References (52)

1. Rheinwald, J. G., and Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinising colonies from single cells. Cell 1975, 6, 331-344.
2. Guillot, F. L. Production of autologous keratinocytes for therapeutic purposes within a pharmaceutical company. J. Soc. Biol. 2001, 195, 75-77.
3. Nanchahal, J.; Dover, R.; Otto, W. R. Allogeneic skin substitutes applied to burns patients. Burns 2002, 28, 254-257.
4. Badiavas, E. V.; Paquette, D.; Carson, P.; Falanga, V. Human chronic wounds treated with bioengineered skin: histologic evidence of host-graft interactions. J. Am. Acad. Dermatol. 2002, 46, 524-530.
5. Currie, L. J.; Martin, R.; Sharpe, J. R.; James, S. E. A comparison of keratinocyte cell sprays with and without fibrin glue. Burns 2003, 29, 677-685.
6. Kuroyanagi, Y.; Yamada, N.; Yamashita, R.; Uchinuma, E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif. Organs 2001, 25, 180-186.
7. Mis, B.; Rolland, E.; Ronfard, V. Combined use of a collagen-based dermal substitute and a fibrin-based cultured epithelium: a step toward a total skin replacement for acute wounds. Burns 2004, 30, 713-719.
8. Llames, S. G.; Del Rio, M.; Larcher, F.; Garcia, E.; Garcia, M.; Escamez, M. J.; Jorcano, J. L.; Holguin, P.; Meana, A. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation 2004, 77, 350-355.
9. Pouliot, R.; Larouche, D.; Auger, F. A.; Juhasz, J.; Xu, W.; Li, H.; Germain, L. Reconstructed human skin produced in vitro and grafted on athymic mice. Transplantation 2002, 73, 1751-1757.
10. Phan, T. T.; Lim, I. J.; Tan, E. K.; Bay, B. H.; Lee, S. T. Evaluation of cell culture on the polyurethane-based membrane (Tegaderm): implication for tissue engineering of skin. Cell Tissue Bank 2005, 6, 91-97.
11. Kim, S. S.; Gwak, S. J.; Choi, C. Y.; Kim, B. S. Skin regeneration using keratinocytes and dermal fibroblasts cultured on biodegradable microspherical polymer beads. J. Biomed. Mater. Res. Part B 2005, 75B, 369-377.
12. Harris, P. A.; Leigh, I. M.; Navsaria, H. A. Pre-confluent keratinocyte grafting: the future for cultured skin replacements? Burns 1998, 24, 591-593.
13. Boyce, S. T.; Goretsky, M. J.; Greenhalgh, D. G.; Kagan, R. J.; Rieman, M. T.; Warden, G. D. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann. Surg. 1995, 222, 743-752.
14. Unal, S.; Ersoz, G.; Demirkan, F.; Arslan, E.; Tutuncu, N.; Sari, A. Analysis of skin-graft loss due to infection: Infection-related graft loss. Ann. Plast. Surg. 2005, 55, 102-106.
15. Krause, K.; Herberger, K.; Brandner, J.; Moll, I.; Augustin M. Treatment of chronic wounds with autologous and allogeneic keratinocytes: state of the art and future perspectives. Proc. 16th EWMA Meeting, Prague 2006, Abstract 085, P76.
16. Horch, R. E.; Kopp, J.; Kneser, U.; Beier, J.; Bach, A. D. Tissue engineering of cultured skin substitutes. J. Cell Mol. Med. 2005, 9, 592-608.
17. Nanchahal, J.; Ward, C. M. New grafts for old? A review of alternatives to autologous skin. Br. J. Plast. Surg. 1992, 45, 354-363.
18. Tay, A. G.; Thang, P. T.; See, P.; Teik, L. S.; Song, C. Cultured subconfluent jeratinocytes on wound polymer dressings in the treatment of burns and chronic wounds. Wounds 2000, 12, 123-129.
19. Sutherland, J.; Robertson, M.; Monaghan, W.; Riehle, M.; Britland, S. T. Facilitated migration of human epidermal keratinocytes and dermal fibroblasts in primary culture. J. Anat. 2000, 198, A65.
20. Tsao, M. C.; Walthall, B. J.; Ham, R. G. Clonal growth of normal human epidermal keratinocytes in a defined medium. J. Cell Physiol. 1982, 110, 219-229.
21. Curtis, A. S. G.; Wilkinson, C.; Wojciak-Stothard, B. Accelerating cell movement. Cell. Eng. 1995, 1, 35-38.
22. Sutherland, J.; Robertson, M.; Monaghan, W.; Riehle, M.; Britland, S. T. Human keratinocytes in primary culture display three distinct phenotypes with differential motility. J. Anat. 2000, 198, A66.
23. Schafer, I. A.; Pandy, M.; Ferguson, R.; Davis, B. R. Comparitive observation of fibroblasts derived from the papillary and reticular dermis of infants and adults: growth kinetics, packing density at confluence and surface morphology. Mech. Ageing Dev. 1985, 31, 275-293.
24. Schmitt-Graff, A.; Desmouliere, A.; Gabbiani, G. Heterogenity of myofibroblast phenotypic features; an example of fibroblastic cell plasticity. Virchows Archiv. 1994, 425, 3-24.
25. Hayflick, L. The cell biology of aging. J. Invest. Derm. 1979, 73, 8-14.
26. Poumay, Y.; Pittelkow, M. R. Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J. Invest. Derm. 1995, 104, 271-276.
27. Kondo, H.; Yonezawa, Y.; Ito, H. Inhibitory effects of human serum on human fetal fibroblast migration: migration-inhibitory activity and substances in serum, and its age-related changes. In Vitro Cell Dev. Biol. Anim. 2000, 36, 256-261.
28. Reed, M. J.; Ferera, N. S.; Vernon, R. B. Impaired migration, intergrin function, and actin cytoskeletal organization in dermal fibroblasts from a subset of aged human donors. Mech. Ageing Dev. 2001, 122, 1203-1220.
29. Kondo, H.; Yonezawa, Y. Changes in the migratory ability of human lung and skin fibroblasts during in vitro ageing and in vivo senescence. Mech. Ageing Dev. 1992, 63, 223-233.
30. Shumakov, V. I.; Onishchenko, N. A.; Rasulov, M. F.; Krasheninnikov, M. E.; Zaidenov, V. A. The use of pre-differentiated mesenchymal bone marrow stem cells for treatment of deep burn wounds. Vestn Khir im I. I. Grekova 2003, 162, 38-42.
31. Andreadis, S. T. Gene transfer to epidermal stem cells: implications for tissue engineering. Expert Opin. Biol. Ther. 2004, 4, 783-800.
32. Pellegrini, G.; Ranno, R.; Stracuzzi, G.; Bondanza, S.; Guerra, L.; Zambruno, G.; Micali, G.; De Luca, M. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 1999, 68, 868-879.
33. Morris, R. J.; Liu, Y.; Marles, L.; Yang, Z.; Trempus, C.; Li, S.; Lin, J. S.; Sawiki, J. A.; Cotsarelis, G. Capturing and profiling adult hair follicle stem cells. Nat. Biotechnol. 2004, 22, 411-417.
34. Prockop, D. J.; Gregory, C. A.; Spees, J. L. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 11917-11923.
35. Shi, C.; Zhu, Y.; Cheng, T. Stem cells and their applications in skin cell therapy. Trends Biotechnol. 2006, 24, 48-52.
36. Miki, T.; Lehmann, T.; Cai, H.; Stolz, D. B.; Strom, S. C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005, 23, 1549-1559.
37. Navsaria, H. A.; Ojeh, N. O.; Moiemen, N.; Griffiths, M. A.; Frame, J. D. Reepithelisation of a full-thickness burn from stem cells of hair follicles micrografted into a tissue engineered dermal template (Integra) Plast. Reconstr. Surg. 2004, 113, 978-981.
38. Britland, S. T; McCaig, C. D. Embryonic Xenopus neurites integrate and respond to simultaneous electrical and adhesive guidance cues. Exp. Cell Res. 1996, 225, 31-38.
39. Chester, D. L.; Blalderson, D. S.; Papini, R. P. A review of keratinocyte delivery to the wound bed. J. Burn Care Rehabil. 2004, 25, 266-275.
40. Noronha, C.; Almeida, A. Local burn treatment-topical antimicrobial agents. Ann. Burns Fire Disasters 2000, 13, 4.
41. Fabreguette, A.; Zhi Hua, S.; Lasne, F.; Damour, O. Evaluation of the cytotoxicity of antiseptics used in current practice on cultures of fibroblasts and keratinocytes. Pathol. Biol. 1994, 42, 888-892.
42. Damour, O.; Hua, S. Z.; Lasne, F.; Villain, M.; Rouselle, P.; Collombel, C. Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns 1992, 18, 479-485.
43. Grant, I.; Green, C.; Martin, R. Stategies to improve the take of commercially available collagen/glycosaminoglycan wound repair material investigated in an animal model. Burns 2001, 27, 699-707.
44. Balin, A. K.; Pratt, L. Dilute povidone-iodine solutions inhibit human skin fibroblast growth. Dermatol. Surg. 2002, 28, 210-214.
45. Zhou, L. H.; Nahm, W. K.; Badiavas, E.; Yufit, T.; Falanga, V. Slow release iodine prepartion and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br. J. Dermatol. 2002, 146, 365-374.
46. Banwell, H. What is the evdeince for tissue regeneration impairment when using a formulation of PVP-I antiseptic on open wounds? Dermatology 2006, 212, 66-76.
47. Goldenheim, P. D. An appraisal of povidone-iodine and wound healing. Postgrad. Med. J. 1993, 69, 97-105.
48. Vogt, P. M.; Hauser, J.; Rossbach, O.; Bosse, B.; Fleischer, W.; Steinau, H. U.; Reimer, K. Polyvinyl pyrrolidone-iodine liposome hydrogel improves epithelialisation by combining moisture and antisepsis. A new concept in wound therapy. Wound Rep. Regen. 2001, 9, 116-122.
49. Vehmeyer-Heeman, M.; Van den Kerckhove, E.; Gorissen, K.; Boeckx, W. Povidone-iodine ointment: no effect of split skin graft healing time. Burns 2005, 31, 489-494.
50. Knutson, R. A.; Merbitz, L. A.; Creekmore, M. A.; Snipes, H. G. Use of sugar and povidone-iodine to enhance wound healing: five year's experience. South. Med. J. 1981, 74, 1329-1335.
51. Selvaggi, G.; Monstrey, S.; Van Landuyt, K.; Hamdi, M.; Blondeel. The role of iodine in antisepsis and wound management: a reappraisal. Acta Chir. Belg. 2003, 103, 241-247.
52. Giacometti, A.; Cirioni, O.; Greganti, G.; Fineo, A.; Ghiselli, R.; Del Prete, M. S.; Mocchegiani, F.; Fileni, B.; Caselli, F.; Petrelli, E.; Saba, V.; Scalise, G. Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. Eur. J. Clin. Microbiol. Infect. Dis. 2002, 21, 553-556.